Pickart Angela M, Martin Ann S, Gross Brianna N, Dellefave-Castillo Lisa M, McCallen Leslie M, Nagaraj Chinmayee B, Rippert Alyssa L, Schultz Catherine P, Ulm Elizabeth A, Armstrong Niki
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
Parent Project Muscular Dystrophy, Washington, District of Columbia, USA.
J Genet Couns. 2025 Feb;34(1):e1892. doi: 10.1002/jgc4.1892. Epub 2024 Apr 29.
The dystrophinopathies encompass the phenotypically variable forms of muscular dystrophy caused by pathogenic variants in the DMD gene. The dystrophinopathies include the most common inherited muscular dystrophy among 46,XY individuals, Duchenne muscular dystrophy, as well as Becker muscular dystrophy and other less common phenotypic variants. With increased access to and utilization of genetic testing in the diagnostic and carrier setting, genetic counselors and clinicians in diverse specialty areas may care for individuals with and carriers of dystrophinopathy. This practice resource was developed as a tool for genetic counselors and other health care professionals to support counseling regarding dystrophinopathies, including diagnosis, health risks and management, psychosocial needs, reproductive options, clinical trials, and treatment. Genetic testing efforts have enabled genotype/phenotype correlation in the dystrophinopathies, but have also revealed unexpected findings, further complicating genetic counseling for this group of conditions. Additionally, the therapeutic landscape for dystrophinopathies has dramatically changed with several FDA-approved therapeutics, an expansive research pathway, and numerous clinical trials. Genotype-phenotype correlations are especially complex and genetic counselors' unique skill sets are useful in exploring and explaining this to families. Given the recent advances in diagnostic testing and therapeutics related to dystrophinopathies, this practice resource is a timely update for genetic counselors and other healthcare professionals involved in the diagnosis and care of individuals with dystrophinopathies.
肌营养不良症包括由DMD基因的致病变异引起的表型多样的肌肉营养不良形式。肌营养不良症包括46,XY个体中最常见的遗传性肌肉营养不良症——杜氏肌营养不良症,以及贝克肌营养不良症和其他不太常见的表型变异。随着基因检测在诊断和携带者筛查中的可及性和应用增加,不同专业领域的遗传咨询师和临床医生可能会为肌营养不良症患者及其携带者提供护理。本实践资源是作为一种工具为遗传咨询师和其他医疗保健专业人员开发的,以支持有关肌营养不良症的咨询,包括诊断、健康风险与管理、心理社会需求、生殖选择、临床试验和治疗。基因检测工作已使肌营养不良症的基因型/表型相关性得以确定,但也揭示了一些意外发现,这使得针对这组疾病的遗传咨询更加复杂。此外,随着几种FDA批准的治疗方法、广泛的研究途径和众多临床试验的出现,肌营养不良症的治疗前景发生了巨大变化。基因型-表型相关性尤其复杂,遗传咨询师独特的技能组合有助于向家庭探索和解释这一点。鉴于最近在与肌营养不良症相关的诊断测试和治疗方面取得的进展,本实践资源为参与肌营养不良症患者诊断和护理的遗传咨询师和其他医疗保健专业人员提供了及时的更新。